Table 1. Antibody levels and kinetics in 20 PCR-confirmed SARS-CoV-2 infected patients.
First week | Second week | Third week | Fourth week or later | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient | Day* | IgG | IgA | Day* | IgG | IgA | Day* | IgG | IgA | Day* | IgG | IgA |
1 | – | – | – | 8 | 0.2 | 0.4 | 15 | 4.5 | 5.3 | 22 | 5.4 | 4.9 |
2 | 6 | 0.5 | 1.3 | 13 | 1.5 | 3.5 | 20 | 2.6 | 3.6 | 28 | 2.7 | 3.0 |
3 | – | – | – | 9 | 0.3 | 0.3 | 16 | 6.2 | 5.6 | 23 | 6.6 | 5.1 |
4 | 7 | 0.3 | 0.3 | – | – | – | 16 | 5.6 | 7.7 | – | – | – |
5 | – | – | – | 12 | 6.7 | 8.1 | 19 | 9.0 | 8.1 | 26 | 10.0 | 7.3 |
6 | – | – | – | 10 | 0.3 | 0.3 | 17 | 4.1 | 7.6 | 24 | 8.4 | 7.6 |
7 | – | – | – | 12 | 0.6 | 1.4 | – | – | – | 27/43 | 1.2/1.6 | 1.7/1.7 |
8 | – | – | – | 14 | 1.7 | 3.5 | – | – | – | 29/45 | 4.1/3.7 | 5.7/3.8 |
9 | – | – | – | 13 | 0.9 | 2.9 | 20 | 1.4 | 4.0 | 27 | 5.5 | 7.4 |
10 | 7 | 0.3 | 0.4 | 14 | 6.9 | 7.8 | 21 | 7.3 | 7.8 | – | – | – |
11 | – | – | – | 8 | 0.8 | 5.1 | 15 | 4.1 | 7.8 | 22 | 7.3 | 7.6 |
12 | 4 | 0.2 | 0.1 | 11 | 1.0 | 6.8 | 18 | 5.5 | 7.0 | – | – | – |
13 | 6 | 0.3 | 0.4 | 13 | 0.8 | 1.5 | 20 | 2.0 | 2.4 | 35 | 2.0 | 1.9 |
14 | – | – | – | 8 | 0.5 | 7.6 | 15 | 0.5 | 6.1 | 24 | 0.5 | 3.7 |
15 | – | – | – | – | – | – | 20 | 7.6 | 7.7 | 27 | 9.3 | 7.3 |
16 | 5 | 0.2 | 0.5 | 12 | 1.0 | 2.7 | 19 | 4.9 | 4.2 | – | – | – |
17 | 7 | 0.8 | 2.5 | – | – | – | 15 | 8.4 | 8.0 | 22 | 8.4 | 8.0 |
18 | – | – | – | – | – | – | – | – | – | 22/36 | 1.1/1.3 | 2.5/2.2 |
19 | 1 | 0.2 | 0.4 | – | – | – | 20 | 3.36 | 6.2 | – | – | – |
20 | – | – | – | – | – | – | – | – | – | 27 | 5.3 | 7.0 |
*time point of serum sampling in days after disease onset (for the one asymptomatic case after positive PCR).